Dynasil corp of america (DYSL)
CashFlow / Quarterly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10
Cash flows from operating activities:
Net income (loss)

-94,000

-268,000

72,000

-102,000

834,000

373,000

1,255,000

-872,000

-461,000

-212,000

-119,000

2,739,000

120,000

215,000

-70,000

69,000

-36,000

367,000

-127,000

-557,000

58,000

254,000

1,445,000

-

-366,361

-7,241,730

-379,342

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,757,194

-331,900

-585,010

370,338

-446,428

1,026,675

396,221

375,177

Adjustments to reconcile net income (loss) to net cash:
Stock compensation expense

83,000

89,000

112,000

78,000

106,000

121,000

137,000

93,000

113,000

116,000

138,000

89,000

106,000

330,000

143,000

119,000

161,000

141,000

92,000

65,000

164,000

119,000

120,000

117,041

90,514

136,612

73,516

255,979

243,057

237,148

199,212

66,388

190,090

118,435

188,530

Foreign exchange loss (gain)

-18,000

-18,000

10,000

-18,000

-4,000

-46,000

26,000

7,000

30,000

36,000

-6,000

-41,000

21,000

-103,000

-35,000

-26,000

-84,000

-81,000

72,000

23,000

-16,000

-7,000

-7,000

-28,659

2,251

57,673

-26,398

-92,415

19,146

-5,610

48,277

-

-

-

-

Depreciation and amortization

364,000

363,000

355,000

338,000

330,000

317,000

311,000

299,000

312,000

302,000

313,000

311,000

328,000

287,000

327,000

325,000

298,000

312,000

293,000

293,000

274,000

269,000

266,000

267,050

459,226

443,717

426,458

534,753

391,773

363,073

380,120

242,330

368,331

294,816

327,596

Provision for doubtful accounts and sales returns

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-55,852

60,970

16,134

-12,512

21,138

1,350

Inventory reserves

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

Deferred income taxes

77,000

69,000

198,000

-62,000

-1,191,000

186,000

-1,243,000

533,000

98,000

-120,000

75,000

-2,730,000

28,000

10,000

43,000

-24,000

-

-

-

-

-

-

-

-

-

-

-

414,483

-9,595

-115,241

-122,727

629,175

-500,804

21,662

-21,562

Disposal loss (gain)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-7,000

0

185,000

30,000

0

1,187,000

0

0

0

87,803

0

0

0

0

-

-

-

-

Non-cash R&D services

-

-

0

0

-

-

37,000

163,000

68,000

33,000

167,000

38,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,887

9,978

19,956

9,978

-

-

-

-

Pension expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

318,000

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Provision for inventory reserves

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,000

6,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other

-33,000

-20,000

-4,000

-10,000

5,000

56,000

-6,000

-44,000

-45,000

-19,000

-14,000

-35,000

-195,000

-47,000

-50,000

-34,000

-99,000

-90,000

-55,000

35,000

-6,000

-62,000

-12,000

-

-44,216

177,662

-28,707

-

-

-

-

-

-

-

-

Other changes in assets and liabilities:
Accounts receivable, net

-1,169,000

1,441,000

447,000

-567,000

426,000

-449,000

478,000

333,000

-17,000

78,000

-526,000

374,000

-1,489,000

209,000

450,000

1,101,000

74,000

82,000

-39,000

79,000

518,000

152,000

-600,000

-326,003

-394,202

-495,560

-607,217

357,258

-705,196

808,317

1,647,098

40,554

-1,606,752

578,370

490,491

Contract assets

-1,085,000

1,131,000

47,000

-10,000

253,000

-253,000

88,000

-88,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Contract assets

-

-

-

17,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

202,000

66,000

-6,000

443,000

-369,000

-126,000

81,000

198,000

202,000

76,000

52,000

280,000

-10,000

27,000

845,000

218,000

-165,000

516,000

26,000

-12,000

-40,000

308,000

224,000

-182,072

-309,219

36,808

322,298

151,761

141,887

113,151

-272,350

175,779

-290,651

61,595

206,597

Costs in excess of billings and unbilled receivables

-

-

-

-

-

-

-

-

-

-303,000

79,000

249,000

42,000

187,000

-150,000

231,000

-247,000

-34,000

54,000

-56,000

449,000

375,000

-755,000

21,089

196,778

186,362

-205,749

317,872

255,763

363,604

184,105

-408,240

-558,110

1,018,834

-325,567

Prepaid expenses and other assets

107,000

-125,000

41,000

139,000

-160,000

147,000

-138,000

-51,000

-55,000

75,000

-74,000

-189,000

-100,000

-58,000

118,000

32,000

-143,000

339,000

-319,000

469,000

12,000

-120,000

219,000

-128,669

-56,831

7,758

76,842

111,030

182,178

157,188

124,256

108,576

39,578

40,871

-13,111

Accounts payable

-42,000

340,000

537,000

-674,000

437,000

199,000

-163,000

-483,000

945,000

213,000

-311,000

-99,000

-102,000

-870,000

762,000

34,000

420,000

-224,000

468,000

-360,000

-46,000

240,000

-9,000

-570,342

93,886

-287,058

399,184

-734,484

1,099,770

457,849

-484,930

-

-

-

-

Accrued expenses and other liabilities

329,000

206,000

138,000

-473,000

240,000

-68,000

359,000

-236,000

262,000

62,000

248,000

-790,000

211,000

-47,000

507,000

-303,000

-159,000

543,000

-91,000

-438,000

-818,000

609,000

274,000

734,433

258,075

-110,984

-852,463

873,816

-388,087

77,761

-92,853

-

-

-

-

Contract liabilities

-

-

-

-95,000

-

-

-

-95,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

11,000

-142,000

2,000

10,000

-8,000

-9,000

136,000

-18,000

99,000

4,000

-76,000

-62,000

-153,000

-167,000

-18,824

-198,236

-102,177

140,355

431,730

0

0

262,942

-

-

-

-

Net cash from operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

64,000

231,000

-698,000

973,000

445,000

1,008,000

-1,590,000

-479,000

1,442,000

163,000

-

1,336,099

3,473

-222,662

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-712,403

Income taxes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-69,569

Net cash from operating activities

1,443,000

-429,000

-538,000

-984,000

1,035,000

1,319,000

728,000

-953,000

1,196,000

-144,000

1,016,000

-580,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

61,996

1,738,697

-327,513

-780,126

672,617

1,715,251

2,425,203

-920,425

Cash flows from investing activities:
Proceeds from sale of property, plant and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

244,000

0

0

4,357,000

0

0

0

80,252

0

0

0

0

-

-

-

-

Purchases of property, plant and equipment

214,000

118,000

357,000

204,000

456,000

783,000

396,000

609,000

458,000

227,000

137,000

91,000

247,000

336,000

328,000

603,000

563,000

291,000

212,000

244,000

340,000

408,000

131,000

122,325

206,898

-99,889

315,568

254,185

76,700

281,987

405,341

248,919

596,239

573,980

124,124

Purchases of intangibles

-

-

0

0

8,000

20,000

29,000

16,000

-9,000

14,000

44,000

20,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash from investing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-360,000

-379,000

-603,000

-563,000

-291,000

-212,000

0

-840,000

-408,000

4,226,000

-

-206,898

99,889

-235,316

-

-

-

-

-

-

-

-

Net cash from investing activities

-214,000

-118,000

-357,000

-204,000

-464,000

-803,000

-425,000

-625,000

-446,000

-241,000

-181,000

-111,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-254,185

-76,700

-281,987

-405,341

-248,919

-896,239

-573,980

-124,124

Cash flows from financing activities:
Proceeds from issuance of common stock

0

4,000

5,000

5,000

4,000

5,000

4,000

4,000

4,000

5,000

4,000

4,000

5,000

4,000

3,000

4,000

3,000

3,000

3,000

3,000

4,000

3,000

4,000

4,511

4,810

5,578

6,110

12,518

18,903

16,568

15,133

11,813

12,984

27,346

83,159

Proceeds from (payments of) bank and subordinated debt, net

-

224,000

188,000

172,000

-

52,000

136,000

141,000

-

136,000

135,000

219,000

-

110,000

51,000

25,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payment of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,000

-

-

-

0

-

-

-

-

-

-

-

-

Net proceeds from issuance of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

450,000

0

0

390,000

315,000

298,000

-18,000

18,000

427,000

5,000

378,000

-

0

0

0

-

-

-

-

-

-

-

-

Principal payments on capital leases

11,000

8,000

7,000

14,000

21,000

22,000

24,000

26,000

26,000

25,000

27,000

28,000

17,000

32,000

23,000

46,000

37,000

37,000

40,000

33,000

32,000

34,000

30,000

26,600

28,741

21,056

0

-

-

-

-

-

-

-

-

Proceeds from (payments of) equipment line of credit, net

0

0

244,000

240,000

461,000

0

0

281,000

0

0

0

0

-104,000

-86,000

-63,000

798,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash from financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-224,000

-134,000

1,121,000

-2,560,000

100,000

-74,000

269,000

980,000

-351,000

-4,038,000

-

-488,216

-479,764

-466,477

-

-

-

-

-

-

-

-

Proceeds from short and long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

300,000

2,566,000

141,000

0

-

-

-

-

-

-

-

-

-

-

-

-

Payments of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,042,000

164,000

19,000

19,000

1,985,000

467,000

4,389,000

764,286

464,285

464,286

472,587

428,097

483,579

473,843

475,159

463,838

465,034

465,035

465,036

Preferred stock dividends paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

33,395

46,375

Net cash from financing activities

-1,471,000

733,000

54,000

59,000

240,000

-69,000

-156,000

118,000

-153,000

-156,000

-158,000

-243,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

670,275

-464,676

-457,275

-460,026

-452,025

-452,050

-471,084

-428,252

Effect of exchange rates on cash and cash equivalents

-

-

26,000

-33,000

-

-

22,000

6,000

28,000

32,000

-2,000

-49,000

-38,000

-62,000

-5,000

-14,000

-33,000

23,000

-25,000

-17,000

-42,000

27,000

-32,000

-17,113

4,479

37,403

-18,525

-49,518

-80,745

199,087

-96,923

-136,230

-52,226

325,333

-14,976

Net change in cash and cash equivalents

-

-

-815,000

-1,162,000

-

-

169,000

-1,454,000

625,000

-509,000

675,000

-983,000

2,375,000

-582,000

-287,000

-194,000

-2,183,000

277,000

697,000

-1,338,000

-381,000

710,000

319,000

-341,537

645,464

-338,999

-942,980

428,568

1,116,576

-867,688

-1,742,416

-164,557

314,736

1,705,472

-1,487,777

Cash paid (received) during the year for: Interest

-

49,000

38,000

45,000

-

32,000

40,000

37,000

-

44,000

45,000

47,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash paid (received) during the year for: Tax payments (refunds)

-

0

10,000

-15,000

-

2,000

1,000

4,000

-

0

3,000

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Assets purchased under capital leases

-

-

-

-

-

-

-

-

-

-

-

-

-

106,000

0

134,000

-

0

0

73,000

0

-67,000

67,000

-

46,273

386,680

0

-

-

-

-

-

-

-

-

Recapitalization of Xcede - conversion of non controlling notes payable to preferred stock

-

-

-

-

-

-

-

-

-

0

-6,207,000

3,104,000

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Subsidiary stock options issued to settle liabilities

-

-

-

-

-

-

-

-

-

0

-7,000

82,000

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Subsidiary debt issued to fund research activities

-

-

-

-

-

-

-

-

-

0

0

500,000

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-